Aluminum-triggered structural modifications and aggregation of β-amyloids

Cellular and Molecular Life Sciences

Volumn 62, Issue 15, 2005, Pages 1724-1733

  Ricchelli, F ^b   Drago, D ^a   Filippi, B ^a   Tognon, G ^a   Zatta, P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Aluminum; Alzheimer; Amyloid; Copper; Metal ions; Zinc

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; COPPER; DEFEROXAMINE MESYLATE; LIPOSOME; ZINC;

ARTICLE; COMPARATIVE STUDY; EXTRACELLULAR SPACE; LIPID BILAYER; MEMBRANE MODEL; PH; PROTEIN AGGREGATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

ALUMINUM; AMYLOID BETA-PROTEIN; CHELATING AGENTS; CIRCULAR DICHROISM; DEFEROXAMINE; FLUORESCENT DYES; HYDROPHOBICITY; LIPOSOMES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE; THIAZOLES;

EID: 23844434035     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5141-0     Document Type: Article

References (58)

1. Munoz D. G. and Feldman H. (2000) Causes of Alzheimer's disease. Can. Med. Assoc. J. 162: 65-72
2. Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356
3. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G. and Cotman C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13: 1676-1687
4. Harper J. D., Wong S. S., Lieber C. M. and Lansbury P. T. Jr (1999) Assembly of Abeta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38: 8972-8980
5. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M. et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95: 6448-6453
6. Klein W. L., Krafft G. A. and Finch C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24: 219-224
7. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S. et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539
8. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W. et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489
9. Hartley D. M., Walsh D. M., Ye C. P., Diehl T., Vasquez S., Vassilev P. M. et al. (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19: 8876-8884
10. Howlett D. R., Perr A. E., Godfrey F., Swatton J. E., Jennings K. H., Spitzfaden C. et al. (1999) Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem. J. 340: 283-289
11. Ward R. V., Jennings K. H., Jepras R., Neville W., Owen D. E., Hawkins J. et al. (2000) Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem. J. 348: 137-144
12. Walsh D. M., Tseng B. P., Rydel R. E., Podlisny M. B. and Selkoe D. J. (2000) The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39: 10831-10839
13. Talaga P. and Queré L. (2002) The plasma membrane: a target and hurdle for the development of anti-Abeta drugs? Curr. Drug Target CNS Neurol. Disord. 1: 567-574
14. McLaurin J., Yang D., Yip C. M. and Fraser P. E. (2000) Review: modulating factors in amyloid-beta fibril formation. J. Struct. Biol. 130: 259-270
15. Bush A. I. (2003) The metallobiology of Alzheimer's disease. Trends Neurosci. 26: 207-214
16. Exley C. and Korchzhkina O. V. (2001) The association of aluminium and β amyloids in Alzheimer's disease. In: Aluminium and Alzheimer's Disease: The Science that Describes the Link, pp. 421-434. Exley C. (ed), Elsevier, Amsterdam
17. Favarato M., Zanoni S., Nicolini M. and Zatta P. (1994) Histofluorimetric aluminum determination in the core of senile plaques from Alzheimer's disease. Life Chem. Rep. 11: 71-78
18. Beauchemin D. and Kisilevsky R. (1998) A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. Anal. Chem. 70: 1026-1029
19. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 47-52
20. Dong J., Atwood C. S., Anderson V. E., Siedlak S. L., Smith M. A., Perry G. et al. (2003) Metal binding and oxidation of amyloid-b within isolated senile plaque cores: raman microscopic evidence. Biochemistry 42: 2768-2773
21. Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R. et al. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61: 1171-1174
22. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M., Romano D. M. et al. (1998) Dramatic aggregation of Alzheimer A beta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273: 12817-12826
23. Atwood C. S., Huang X., Moir R. D., Tanzi R. E. and Bush A. I. (1999) Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met. Ions Biol. Syst. 36: 309-364
24. 42 in a manner which may have consequences for metal chelation therapy in Alzheimer disease. J. Alzheimer's Dis. 6: 291-301
25. Zatta P., Favarato M. and Nicolini M. (1993) Deposition of aluminum in brain tissues of rats exposed to inhalation of aluminum acetylacetonate. Neuroreport 4: 1119-112
26. Bala Gupta V., Anitha S., Hedge M. L., Zecca L., Garruto M. R., Ravid R. et al. (2005) Aluminium in Alzheimer's disease: are we still at a crossroad? Cell Mol. Life Sci. 62: 143-158
27. Meiri H., Banin E., Roll M. and Rousseau A. (1993) Toxic effects of aluminum on nerve cells and synaptic transmission. Prog. Neurobiol. 40: 89-121
28. Good P. F. and Perl D. P. (1993) Aluminium in Alzheimer's? Nature 362: 418-422
29. Kawahara M., Muramoto K., Kobayashi K., Mori H. and Kuroda Y. (1994) Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochem. Biophys. Res. Commun. 198: 531-535
30. Kawahara M., Kato M. and Kuroda Y. (2001) Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res. Bull. 55: 211-217
31. Exley C., Price N. C., Kelly S. M. and Birchall J. D. (1993) An interaction of beta-amyloid with aluminium in vitro. FEBS Lett. 324: 293-295
32. Evans P. and Harrington C. (1998) Aluminosilicate particulate and beta-amyloid in vitro interactions: a model of Alzheimer plaque formation. Biochem. Soc. Trans. 26: S251
33. Practicò D., Urhyu K., Sung S., Tang S., Trojanowski J. Q. and Lee V. M. (2002) Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 16: 1138-1140
34. Zatta P., Zambenedetti P., Bruna V. and Filippi B. (1994) Activation of acetylcholinesterase by aluminum (III): the relevance of the metal species. Neuroreport 5: 1777-1780
35. Bohm G., Muhr R. and Jaenicke R. (1992) Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. 5: 191-195
36. Kremer J. M., Esker M. W., Pathmamanoharan C. and Wiersema P. H. (1977) Vesicles of variable diameter prepared by a modified injection method. Biochemistry 16: 3932-3935
37. Garzon-Rodriguez W., Yatsimirsky A. K. and Glabe C. G. (1999) Binding of Zn(II), Cu(II) and Fe(III) ions to Alzheimer's Aβ peptide studied by fluorescence. Bioorg. Med. Chem. Lett. 9: 2243-2248
38. Kasha M. (1952) Collisional perturbation of spin-orbital coupling and the mechanism of fluorescence quenching: a visual demonstration of the perturbation. J. Chem. Phys. 20: 71-74
39. Uversky V. N., Lee H. J., Li J., Fink A. L. and Lee S. J. (2001) Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276: 43495-43498
40. LeVine H. (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2: 404-410
41. Arispe N., Rojas E. and Pollard H. B. (1993) Alzheimer's disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc. Natl. Acad. Sci. USA 90: 567-571
42. Hartmann H., Eckert A. and Muller W. E. (1994) Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Biochem. Biophys. Res. Commun. 200: 1185-1192
43. McLaurin J. and Chakrabartty A. (1997) Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245: 355-363
44. Lin H., Bhatia R. and Lal R. (2001) Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15: 2433-2444
45. Zatta P., Ibn-Lkhayat-Idrissi M., Zambenedetti P., Kilyen M. and Kiss T. (2002) In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res. Bull. 59: 41-45
46. Szöllosi J. (1994) Fluidity/viscosity of biological membranes. In: Mobility and Proximity in Biological Membranes, pp 137-208, Damianovich S., Edidin M., Tron L. and Szöllosi J. (eds), CRC Press, Boca Raton
47. Kruck T. P. A. and Burrow T. E. (2002) Synthesis of Feralex, a novel aluminium/iron chelating compound. J. Inorg. Biochem. 88: 9-24
48. Cuajungco M. P., Faget K. Y., Huang R. E., Tanzi R. E. and Bush A. I. (2000) Metal chelation as a potential therapy for Alzheimer's disease. Ann. N. Y. Acad. Sci. 920: 293-304
49. Di Vaira M., Bazzicalupi C., Orioli PL., Messori L., Bruni B. and Zatta P. (2004) Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes. Inorg. Chem. 43: 3795-3797
50. Kopito R. R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10: 524-530
51. Zatta P. and Alfrey A.C. (eds) (1995) Aluminum Toxicity in Infants' Health and Disease, Wold Sci, Singapore
52. Bush A. I. and Tanzi R. E. (2002) The galvanization of β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 99: 7317-7319
53. Miura T., Suzuki K., Kohata N. and Takeuchi H. (2000) Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 39: 7024-7031
54. Fasman G. D. (1996) Aluminum and Alzheimer's disease: model studies. Coord. Chem. Rev. 149: 125-165
55. Lakowicz J. R. (1983) Principles of Fluorescence Spectroscopy, Plenum, New York
56. Kremer J. J., Sklansky D. J. and Murphy R. M. (2001) Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry 40: 8563-8571
57. Tamaoka A., Sawamura N., Fukushima T., Shoji, S., Matsubara E., Shoji M. et al. (1997) Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Sci. 148: 41-45
58. Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W. et al. (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337: 1304-1308